Effect of liver function on clinical outcomes in patients with unresectable hepatocellular carcinoma treated with first-line atezolizumab-bevacizumab: An Asia-Pacific multicenter retrospective analysis.
- DOI
- 10.1016/j.aohep.2026.102441
- Published
- 2026 Sep 15
- Container
- Annals of hepatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.aohep.2026.102441,
title = {Effect of liver function on clinical outcomes in patients with unresectable hepatocellular carcinoma treated with first-line atezolizumab-bevacizumab: An Asia-Pacific multicenter retrospective analysis.},
author = {Shin Y and Kim YJ and Tai DWM and Kim HD and Choi J and Choi WM and Chung SW and Chan LL and Liu TH and Kim I and Lee J and Hsu C and Chan SL and Yoo C},
year = {2026},
journal = {Annals of hepatology},
doi = {10.1016/j.aohep.2026.102441},
url = {https://doi.org/10.1016/j.aohep.2026.102441}
}RIS
TY - JOUR TI - Effect of liver function on clinical outcomes in patients with unresectable hepatocellular carcinoma treated with first-line atezolizumab-bevacizumab: An Asia-Pacific multicenter retrospective analysis. AU - Shin Y AU - Kim YJ AU - Tai DWM AU - Kim HD AU - Choi J AU - Choi WM AU - Chung SW AU - Chan LL AU - Liu TH AU - Kim I AU - Lee J AU - Hsu C AU - Chan SL AU - Yoo C PY - 2026 JO - Annals of hepatology DO - 10.1016/j.aohep.2026.102441 UR - https://doi.org/10.1016/j.aohep.2026.102441 ER -
APA
Y, S., YJ, K., DWM, T., HD, K., J, C., WM, C., SW, C., LL, C., TH, L., I, K., J, L., C, H., SL, C., & C, Y. (2026). Effect of liver function on clinical outcomes in patients with unresectable hepatocellular carcinoma treated with first-line atezolizumab-bevacizumab: An Asia-Pacific multicenter retrospective analysis.. Annals of hepatology. https://doi.org/10.1016/j.aohep.2026.102441
Source records
- pubmed · retrieved 2026-09-26T09:01:23.278Z